Explore our latest articles, insights, and stories from the frontlines of clinical trials.
Practical Q&A on home asthma, COPD digital-monitoring, lung cancer immunotherapy, and post-COVID rehab trials—steps, caregiver tips, eligibility, and hopeful next steps.
Practical Q&A on GLP-1 impacts, seasonal enrollment tactics, patient-centric stroke design, and translating psilocybin research into care, with 2024-2025 insights and hope for patients.
An analytical look at how federated EHR analytics, synthetic control arms, bias-mitigation workflows, and MLOps combine to shorten timelines, protect patient outcomes, and train clinicians in modern trial science.
Explore how wearables, AI, mobile apps and blockchain are reshaping trials—improving outcomes, cutting costs, and involving patient groups for fairer research.
Explore how wearables, decentralized genomics, GLP-1 digital therapeutics, and psilocybin safety platforms are reshaping trials, addressing patient fears, and improving measurable outcomes.
A friendly Q&A on wearables and sensors for asthma/COPD trials — how wearable spirometers help manage asthma, what to expect in COPD home oxygen trials, inhaler sensors and preparing kids with action plans.
Practical steps for families: how biologics, wearables, and trials can improve care for kids with autoimmune disease—plus what to bring to the first visit and how to manage costs and flu season.
New clinical trials use Wearable AI for early stroke symptom detection, smart inhaler networks for fall flu surveillance, blockchain consent for breast cancer trials, and passive smartphone phenotyping for chronic low back pain.
Community flu trials are expanding—discover how to join, why intranasal vaccines matter, how to manage side effects at home, and practical post-exposure options for families, with encouragement for those newly diagnosed.
